Loading...
Last update:  December 3, 2017
19:22 +1GMT

Allergenic Molecule  Fel d 2Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
5.3.1 - Source Exposed (Symptoms, IgE)2014AustraliaIgE8612.79020140225, Hales BJ
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE373.00020140127, Konradsen JR
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE284.00020140127, Konradsen JR
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE766.60020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE352.86020130605, Simon D
4.1.5 - Heterologous Source Sensitized (IgE)2013LuxembourgIgE352.86020131227, Hilger C
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2013United StatesIgE8100.00020130128, Posthumus J
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE966.25020120528, Patelis A
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE994.04020110223, De Knop KJ
6.2 - General Population (Adults)2012SwedenIgE3712.16020120528, Patelis A
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1003.00020111214, Zheng YW
5.3.1 - Source Exposed (Symptoms, IgE)2011LuxembourgIgE4352.27020111122, Hilger C
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE868.13920101214, Gadisseur R
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2025.00020091005, Ott H
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE224.55020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE375.40520090826, Ebo DG
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2003AustriaIgE2035.000
3.2.1 - Source Sensitized (IgE)1999NetherlandsIgE50916.700
5.3.1 - Source Exposed (Symptoms, IgE)1996FranceIgE4339.000
Developed by
Panservice